GARCIA PETER S
Insider CIK 1188956 · DRRX Director · ALXO Chief Financial Officer · BTX Chief Financial Officer · PDLI Vice President, CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | D To issuer deriv | 2025-09-11 | 2025-09-12 | 7,000 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | U Tender | 2025-09-11 | 2025-09-12 | 12,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise deriv | 2025-09-09 | 2025-09-11 | 5,500 | — | $0 | 0 | SEC↗ |
| DRRX DURECT CORP | M Exercise | 2025-09-09 | 2025-09-11 | 5,500 | $1.22 | $6.7K | 12,500 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2024-09-25 | 2024-09-27 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | F Tax w/h | 2024-08-14 | 2024-08-16 | 761 | $2.58 | $2.0K | 121,516 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | F Tax w/h | 2024-06-28 | 2024-07-02 | 1,789 | $6.03 | $10.8K | 122,277 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2024-06-13 | 2024-06-17 | 12,000 | $8.53 | $102.4K | 122,348 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2024-06-13 | 2024-06-24 | 12,000 | $8.53 | $102.4K | 122,348 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2024-02-14 | 2024-02-16 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award | 2024-02-14 | 2024-02-16 | 25,000 | — | $0 | 110,348 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2023-12-29 | 2024-01-03 | 1,893 | $15.04 | $28.5K | 85,348 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2023-07-25 | 2023-07-27 | 101,000 | — | $0 | 101,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award | 2023-07-25 | 2023-07-27 | 32,000 | — | $0 | 86,738 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2023-06-30 | 2023-07-05 | 887 | $7.34 | $6.5K | 54,738 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2023-06-21 | 2023-06-23 | 5,500 | — | $0 | 5,500 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2022-12-29 | 2023-01-03 | 893 | $11.07 | $9.9K | 53,723 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2022-08-05 | 2022-08-09 | 95,000 | — | $0 | 95,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award | 2022-08-05 | 2022-08-09 | 29,000 | — | $0 | 55,178 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2022-02-07 | 2022-02-08 | 8,363 | — | $0 | 20,813 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2022-02-07 | 2022-02-08 | 6,637 | — | $0 | 89,022 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2022-02-07 | 2022-02-08 | 6,637 | $4.08 | $27.1K | 16,120 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2022-02-07 | 2022-02-08 | 8,363 | $4.81 | $40.2K | 24,483 | SEC↗ |
| DRRX DURECT CORP | A Award deriv | 2021-12-13 | 2021-12-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-10-18 | 2021-10-19 | 7,229 | — | $0 | 60,468 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 2,851 | $54.33 | $154.9K | 13,709 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-10-18 | 2021-10-19 | 7,229 | $4.08 | $29.5K | 16,560 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 189 | $59.06 | $11.2K | 9,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 1,903 | $55.15 | $105.0K | 11,806 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 438 | $58.30 | $25.5K | 9,520 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 411 | $57.54 | $23.6K | 9,958 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-10-18 | 2021-10-19 | 1,437 | $56.09 | $80.6K | 10,369 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-09-17 | 2021-09-17 | 11,345 | — | $0 | 67,697 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-17 | 2021-09-17 | 1,027 | $77.84 | $79.9K | 19,649 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-17 | 2021-09-17 | 273 | $80.22 | $21.9K | 10,431 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-17 | 2021-09-17 | 1,746 | $79.46 | $138.7K | 10,704 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-17 | 2021-09-17 | 7,199 | $78.61 | $565.9K | 12,450 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-17 | 2021-09-17 | 1,100 | $81.19 | $89.3K | 9,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-09-17 | 2021-09-17 | 11,345 | $4.08 | $46.3K | 20,676 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-09-16 | 2021-09-17 | 1,426 | — | $0 | 79,042 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-09-16 | 2021-09-17 | 1,426 | $80.43 | $114.7K | 9,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-09-16 | 2021-09-17 | 1,426 | $4.08 | $5.8K | 10,757 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-08-23 | 2021-08-24 | 19,370 | — | $0 | 80,468 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-08-23 | 2021-08-24 | 40,630 | — | $0 | 95,659 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 10,743 | $75.71 | $813.4K | 11,982 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 19,448 | $75.09 | $1.46M | 22,725 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 4,008 | $73.57 | $294.9K | 42,173 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 18,060 | $72.66 | $1.31M | 46,181 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 35 | $77.56 | $2.7K | 9,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 1,593 | $70.86 | $112.9K | 67,738 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-08-23 | 2021-08-24 | 60,000 | $4.08 | $244.8K | 69,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 2,616 | $76.66 | $200.5K | 9,366 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-23 | 2021-08-24 | 3,497 | $72.03 | $251.9K | 64,241 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-08-17 | 2021-08-18 | 10,000 | — | $0 | 136,289 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-17 | 2021-08-18 | 2,368 | $65.83 | $155.9K | 12,276 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-17 | 2021-08-18 | 2,400 | $68.34 | $164.0K | 9,371 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-17 | 2021-08-18 | 505 | $67.13 | $33.9K | 11,771 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-17 | 2021-08-18 | 40 | $68.62 | $2.7K | 9,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | S Sale | 2021-08-17 | 2021-08-18 | 4,687 | $65.24 | $305.8K | 14,644 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-08-17 | 2021-08-18 | 10,000 | $4.08 | $40.8K | 19,331 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2021-07-30 | 2021-08-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise deriv | 2021-01-28 | 2021-01-29 | 6,128 | — | $0 | 146,289 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | M Exercise | 2021-01-28 | 2021-01-29 | 6,128 | $4.08 | $25.0K | 9,128 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 3,000 | $19.00 | $57.0K | 3,000 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2020-07-16 | 2020-07-17 | 88,137 | — | $0 | 88,137 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-03-28 | 2019-04-01 | 628,930 | — | $0 | 628,930 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-03-28 | 2019-04-16 | 641,025 | — | $0 | 641,025 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2018-12-27 | 2018-12-28 | 226,442 | — | $0 | 225,029 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | F Tax w/h | 2018-12-27 | 2018-12-28 | 3,553 | $3.02 | $10.7K | 451,471 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2018-09-25 | 2018-09-27 | 339,678 | — | $0 | 339,678 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-12 | 694,900 | — | $0 | 694,900 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2017-12-15 | 2017-12-19 | 17,818 | — | $0 | 455,024 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2017-03-24 | 2017-03-27 | 10,000 | $1.98 | $19.8K | 462,842 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2017-03-24 | 2017-03-27 | 5,000 | $1.98 | $9.9K | 467,842 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2017-03-24 | 2017-03-27 | 5,000 | $1.98 | $9.9K | 472,842 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2017-03-24 | 2017-03-27 | 350 | $1.98 | $693 | 452,842 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2017-03-24 | 2017-03-27 | 4,650 | $1.97 | $9.2K | 452,492 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-03-04 | 2017-03-07 | 212,669 | $2.04 | $433.8K | 447,842 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | D To issuer | 2016-12-13 | 2016-12-15 | 1,919 | — | $0 | 235,173 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2016-08-09 | 2016-08-10 | 5,000 | $3.00 | $15.0K | 237,092 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2016-08-09 | 2016-08-10 | 5,000 | $2.99 | $15.0K | 232,092 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-01-26 | 2016-01-28 | 101,051 | $3.22 | $325.4K | 227,092 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-12-15 | 2015-12-16 | 5,000 | $3.64 | $18.2K | 126,041 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-12-14 | 2015-12-16 | 10,000 | $3.42 | $34.2K | 121,041 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-09-29 | 2015-10-05 | 15,169 | $4.95 | $75.1K | 111,041 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-08-14 | 2015-08-17 | 2,400 | $5.79 | $13.9K | 88,272 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-08-14 | 2015-08-17 | 300 | $5.80 | $1.7K | 95,872 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-08-14 | 2015-08-17 | 7,300 | $5.79 | $42.3K | 95,572 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-08-13 | 2015-08-17 | 2,200 | $5.86 | $12.9K | 85,872 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2015-08-13 | 2015-08-17 | 7,800 | $5.86 | $45.7K | 83,672 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-01-28 | 2015-01-30 | 32,847 | $7.62 | $250.3K | 75,872 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2014-04-10 | 2014-04-15 | 30,450 | $8.22 | $250.3K | 43,025 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2013-05-23 | 2013-05-23 | 12,575 | $8.35 | $105.0K | 12,575 | SEC↗ |
| BTX BIOTIME INC | J Other deriv | 2013-02-20 | 2013-02-22 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2012-03-19 | 2012-03-19 | 3,300 | $4.67 | $15.4K | 7,000 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2012-03-19 | 2012-03-19 | 1,700 | $4.68 | $8.0K | 3,700 | SEC↗ |